An in vivo human-plasmablast enrichment technique allows rapid identification of therapeutic influenza A antibodies

Cell Host and Microbe

Volumn 14, Issue 1, 2013, Pages 93-103

  Nakamura, Gerald ^a   Chai, Ning ^a   Park, Summer ^a   Chiang, Nancy ^a   Lin, Zhonghua ^a   Chiu, Henry ^a   Fong, Rina ^a   Yan, Donghong ^a   Kim, Janice ^a   Zhang, Juan ^a   Lee, Wyne P ^a   Estevez, Alberto ^a   Coons, Mary ^a   Xu, Min ^a   Lupardus, Patrick ^a   Balazs, Mercedesz ^a   Swem, Lee R ^a  

^a GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY; OSELTAMIVIR; VIRUS ANTIBODY;

ANIMAL EXPERIMENT; ANTIBODY BLOOD LEVEL; ANTIBODY ISOLATION; ANTIGEN SPECIFICITY; ARTICLE; CELL TYPE; DISEASE SEVERITY; ENRICHMENT CULTURE; FERRET; HUMAN; HUMAN CELL; IN VIVO STUDY; INFLUENZA A; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMABLAST; PRIORITY JOURNAL; SINGLE DRUG DOSE; VACCINATION;

EID: 84880427552     PISSN: 19313128     EISSN: 19346069     Source Type: Journal    
DOI: 10.1016/j.chom.2013.06.004     Document Type: Article

References (35)

1. P.D. Adams, P.V. Afonine, G. Bunkóczi, V.B. Chen, I.W. Davis, N. Echols, J.J. Headd, L.W. Hung, G.J. Kapral, and R.W. Grosse-Kunstleve PHENIX: a comprehensive Python-based system for macromolecular structure solution Acta Crystallogr. D Biol. Crystallogr. 66 2010 213 221
2. F.Y. Aoki, M.D. Macleod, P. Paggiaro, O. Carewicz, A. El Sawy, C. Wat, M. Griffiths, E. Waalberg, P. Ward IMPACT Study Group Early administration of oral oseltamivir increases the benefits of influenza treatment J. Antimicrob. Chemother. 51 2003 123 129
3. M.F. Bachmann, U. Kalinke, A. Althage, G. Freer, C. Burkhart, H. Roost, M. Aguet, H. Hengartner, and R.M. Zinkernagel The role of antibody concentration and avidity in antiviral protection Science 276 1997 2024 2027
4. G.C. Bosma, R.P. Custer, and M.J. Bosma A severe combined immunodeficiency mutation in the mouse Nature 301 1983 527 530
5. N.M. Bouvier, and P. Palese The biology of influenza viruses Vaccine 26 Suppl 4 2008 D49 D53
6. V.B. Chen, W.B. Arendall 3rd, J.J. Headd, D.A. Keedy, R.M. Immormino, G.J. Kapral, L.W. Murray, J.S. Richardson, and D.C. Richardson MolProbity: all-atom structure validation for macromolecular crystallography Acta Crystallogr. D Biol. Crystallogr. 66 2010 12 21
7. D. Corti, J. Voss, S.J. Gamblin, G. Codoni, A. Macagno, D. Jarrossay, S.G. Vachieri, D. Pinna, A. Minola, and F. Vanzetta A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins Science 333 2011 850 856
8. S. Depraetere, L. Verhoye, G. Leclercq, and G. Leroux-Roels Human B cell growth and differentiation in the spleen of immunodeficient mice J. Immunol. 166 2001 2929 2936
9. C. Dreyfus, N.S. Laursen, T. Kwaks, D. Zuijdgeest, R. Khayat, D.C. Ekiert, J.H. Lee, Z. Metlagel, M.V. Bujny, and M. Jongeneelen Highly conserved protective epitopes on influenza B viruses Science 337 2012 1343 1348
10. J. Dushoff, J.B. Plotkin, C. Viboud, D.J. Earn, and L. Simonsen Mortality due to influenza in the United States - an annualized regression approach using multiple-cause mortality data Am. J. Epidemiol. 163 2006 181 187
11. D.C. Ekiert, G. Bhabha, M.A. Elsliger, R.H. Friesen, M. Jongeneelen, M. Throsby, J. Goudsmit, and I.A. Wilson Antibody recognition of a highly conserved influenza virus epitope Science 324 2009 246 251
12. D.C. Ekiert, R.H. Friesen, G. Bhabha, T. Kwaks, M. Jongeneelen, W. Yu, C. Ophorst, F. Cox, H.J. Korse, and B. Brandenburg A highly conserved neutralizing epitope on group 2 influenza A viruses Science 333 2011 843 850
13. P. Emsley, and K. Cowtan Coot: model-building tools for molecular graphics Acta. Crystallogr. D. Biol. Crystallogr. 60 2004 2126 2132
14. C. Fraser, C.A. Donnelly, S. Cauchemez, W.P. Hanage, M.D. Van Kerkhove, T.D. Hollingsworth, J. Griffin, R.F. Baggaley, H.E. Jenkins, E.J. Lyons WHO Rapid Pandemic Assessment Collaboration Pandemic potential of a strain of influenza A (H1N1): early findings Science 324 2009 1557 1561
15. R. Kandel, and K.L. Hartshorn Prophylaxis and treatment of influenza virus infection BioDrugs 15 2001 303 323
16. B. Klein, K. Tarte, M. Jourdan, K. Mathouk, J. Moreaux, E. Jourdan, E. Legouffe, J. De Vos, and J.F. Rossi Survival and proliferation factors of normal and malignant plasma cells Int. J. Hematol. 78 2003 106 113
17. E. Krissinel, and K. Henrick Inference of macromolecular assemblies from crystalline state J. Mol. Biol. 372 2007 774 797
18. D. Lingwood, P.M. McTamney, H.M. Yassine, J.R. Whittle, X. Guo, J.C. Boyington, C.J. Wei, and G.J. Nabel Structural and genetic basis for development of broadly neutralizing influenza antibodies Nature 489 2012 566 570
19. Y. Matsuoka, E.W. Lamirande, and K. Subbarao The ferret model for influenza Curr. Protoc. Microbiol. Chapter 15 2009 Unit 15G.2
20. A.J. McCoy, R.W. Grosse-Kunstleve, P.D. Adams, M.D. Winn, L.C. Storoni, and R.J. Read Phaser crystallographic software J. Appl. Cryst. 40 2007 658 674
21. G.N. Murshudov, A.A. Vagin, and E.J. Dodson Refinement of macromolecular structures by the maximum-likelihood method Acta Crystallogr. D Biol. Crystallogr. 53 1997 240 255
22. K.G. Nicholson, F.Y. Aoki, A.D. Osterhaus, S. Trottier, O. Carewicz, C.H. Mercier, A. Rode, N. Kinnersley, P. Ward Neuraminidase Inhibitor Flu Treatment Investigator Group Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial Lancet 355 2000 1845 1850
23. Y. Okuno, Y. Isegawa, F. Sasao, and S. Ueda A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains J. Virol. 67 1993 2552 2558
24. R. Pejchal, K.J. Doores, L.M. Walker, R. Khayat, P.S. Huang, S.K. Wang, R.L. Stanfield, J.P. Julien, A. Ramos, and M. Crispin A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shield Science 334 2011 1097 1103
25. J. Sui, W.C. Hwang, S. Perez, G. Wei, D. Aird, L.M. Chen, E. Santelli, B. Stec, G. Cadwell, and M. Ali Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses Nat. Struct. Mol. Biol. 16 2009 265 273
26. Schrödinger, LLC. The PyMOL Molecular Graphics System, version 1.5.0.4.
27. W.W. Thompson, D.K. Shay, E. Weintraub, L. Brammer, N. Cox, L.J. Anderson, and K. Fukuda Mortality associated with influenza and respiratory syncytial virus in the United States JAMA 289 2003 179 186
28. W.W. Thompson, D.K. Shay, E. Weintraub, L. Brammer, C.B. Bridges, N.J. Cox, and K. Fukuda Influenza-associated hospitalizations in the United States JAMA 292 2004 1333 1340
29. M. Throsby, E. van den Brink, M. Jongeneelen, L.L. Poon, P. Alard, L. Cornelissen, A. Bakker, F. Cox, E. van Deventer, and Y. Guan Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells PLoS ONE 3 2008 e3942
30. J.J. Treanor, F.G. Hayden, P.S. Vrooman, R. Barbarash, R. Bettis, D. Riff, S. Singh, N. Kinnersley, P. Ward, R.G. Mills US Oral Neuraminidase Study Group Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial JAMA 283 2000 1016 1024
31. L.M. Walker, M. Huber, K.J. Doores, E. Falkowska, R. Pejchal, J.P. Julien, S.K. Wang, A. Ramos, P.Y. Chan-Hui, M. Moyle Protocol G Principal Investigators Broad neutralization coverage of HIV by multiple highly potent antibodies Nature 477 2011 466 470
32. R. Welliver, A.S. Monto, O. Carewicz, E. Schatteman, M. Hassman, J. Hedrick, H.C. Jackson, L. Huson, P. Ward, J.S. Oxford Oseltamivir Post Exposure Prophylaxis Investigator Group Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial JAMA 285 2001 748 754
33. D.C. Wiley, and J.J. Skehel The structure and function of the hemagglutinin membrane glycoprotein of influenza virus Annu. Rev. Biochem. 56 1987 365 394
34. X. Wu, Z.Y. Yang, Y. Li, C.M. Hogerkorp, W.R. Schief, M.S. Seaman, T. Zhou, S.D. Schmidt, L. Wu, and L. Xu Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1 Science 329 2010 856 861
35. R. Xu, and I.A. Wilson Structural characterization of an early fusion intermediate of influenza virus hemagglutinin J. Virol. 85 2011 5172 5182